Literature DB >> 18000095

Role of the thyrotropin-releasing hormone stimulation test in diagnosis of congenital central hypothyroidism in infants.

David A van Tijn1, Jan J M de Vijlder, Thomas Vulsma.   

Abstract

CONTEXT: A shortage of thyroid hormone during prenatal life and the first years after birth results in a spectrum of neuropsychological disorders, depending on the duration and severity of the deficiency. In the case of congenital hypothyroidism of central origin (CH-C), the majority of patients have multiple pituitary hormone deficiencies (MPHD). This condition poses an additional threat to postnatal central nervous system development, primarily on account of neuroglycopenia due to ACTH/cortisol deficiency with or without additional GH deficiency. Therefore, in CH-C, rapid diagnosis is even more urgent than in congenital hypothyroidism of thyroidal origin.
OBJECTIVE: In the assessment of hypothalamic-pituitary-thyroid function, we considered the pituitary response to iv administration of TRH (TRH test) pivotal. We evaluated the usefulness of the TRH test in a cohort of infants with neonatal congenital hypothyroidism screening results indicative of CH-C by analyzing the results within the framework of investigations of the anatomical and functional integrity of the hypothalamo-hypophyseal system. DESIGN AND
SETTING: The study was a Dutch nationwide prospective study (1994-1996). Patients were included if neonatal congenital hypothyroidism screening results were indicative of CH-C and patients could be tested within 3 months of birth. PATIENTS: Ten male and five female infants with CH-C, detected by neonatal screening, and six infants with false-positive screening results, nonthyroidal illness, or transient hypothyroidism, were included in the study. MAIN OUTCOME MEASURES: Results of TRH tests, within the framework of extensive endocrinological examinations and cerebral magnetic resonance imaging, were measured.
RESULTS: All patients with type 3 TSH responses to TRH had MPHD, and the majority (67%) of patients with type 2 responses had isolated TSH deficiency.
CONCLUSIONS: The TRH test has a pivotal role in the diagnosis of TSH deficiency in young infants. Abnormal TRH test results, especially a type 3 response, urge immediate assessment of integral hypothalamic-pituitary function because the majority of patients have MPHD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18000095     DOI: 10.1210/jc.2006-2656

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  11 in total

Review 1.  Central Hypothyroidism Due to a TRHR Mutation Causing Impaired Ligand Affinity and Transactivation of Gq.

Authors:  Marta García; Jesús González de Buitrago; Mireia Jiménez-Rosés; Leonardo Pardo; Patricia M Hinkle; José C Moreno
Journal:  J Clin Endocrinol Metab       Date:  2017-07-01       Impact factor: 5.958

2.  The dynamic pituitary response to escalating-dose TRH stimulation test in hypothyroid patients treated with liothyronine or levothyroxine replacement therapy.

Authors:  Sahzene Yavuz; Joyce D Linderman; Sheila Smith; Xiongce Zhao; Frank Pucino; Francesco S Celi
Journal:  J Clin Endocrinol Metab       Date:  2013-04-12       Impact factor: 5.958

3.  Central hypothyroidism.

Authors:  Jayaraman Muthukrishnan; K V S Harikumar; Abhyuday Verma; Kirtikumar Modi
Journal:  Indian J Pediatr       Date:  2010-01       Impact factor: 1.967

4.  SCREENING OF PROP-1, LHX2 AND POU1F1 MUTATIONS IN PATIENTS WITH ECTOPIC POSTERIOR PITUITARY GLAND.

Authors:  H A Korkmaz; U Karaarslan; C Eraslan; D Atila; F Hazan; V Barışık; E S Ata; O Etlik; M Yıldız; B Ozkan
Journal:  Acta Endocrinol (Buchar)       Date:  2018 Jul-Sep       Impact factor: 0.877

5.  Loss-of-function mutations in IGSF1 cause an X-linked syndrome of central hypothyroidism and testicular enlargement.

Authors:  Yu Sun; Beata Bak; Nadia Schoenmakers; A S Paul van Trotsenburg; Wilma Oostdijk; Peter Voshol; Emma Cambridge; Jacqueline K White; Paul le Tissier; S Neda Mousavy Gharavy; Juan P Martinez-Barbera; Wilhelmina H Stokvis-Brantsma; Thomas Vulsma; Marlies J Kempers; Luca Persani; Irene Campi; Marco Bonomi; Paolo Beck-Peccoz; Hongdong Zhu; Timothy M E Davis; Anita C S Hokken-Koelega; Daria Gorbenko Del Blanco; Jayanti J Rangasami; Claudia A L Ruivenkamp; Jeroen F J Laros; Marjolein Kriek; Sarina G Kant; Cathy A J Bosch; Nienke R Biermasz; Natasha M Appelman-Dijkstra; Eleonora P Corssmit; Guido C J Hovens; Alberto M Pereira; Johan T den Dunnen; Michael G Wade; Martijn H Breuning; Raoul C Hennekam; Krishna Chatterjee; Mehul T Dattani; Jan M Wit; Daniel J Bernard
Journal:  Nat Genet       Date:  2012-11-11       Impact factor: 38.330

Review 6.  Update on some aspects of neonatal thyroid disease.

Authors:  Tamar Simpser; Robert Rapaport
Journal:  J Clin Res Pediatr Endocrinol       Date:  2010-08-01

7.  Central hypothyroidism.

Authors:  Vishal Gupta; Marilyn Lee
Journal:  Indian J Endocrinol Metab       Date:  2011-07

8.  The syndrome of central hypothyroidism and macroorchidism: IGSF1 controls TRHR and FSHB expression by differential modulation of pituitary TGFβ and Activin pathways.

Authors:  Marta García; Raquel Barrio; Montserrat García-Lavandeira; Angela R Garcia-Rendueles; Adela Escudero; Esther Díaz-Rodríguez; Darya Gorbenko Del Blanco; Ana Fernández; Yolanda B de Rijke; Elena Vallespín; Julián Nevado; Pablo Lapunzina; Vilborg Matre; Patricia M Hinkle; Anita C S Hokken-Koelega; María P de Miguel; José Manuel Cameselle-Teijeiro; Manuel Nistal; Clara V Alvarez; José C Moreno
Journal:  Sci Rep       Date:  2017-03-06       Impact factor: 4.379

Review 9.  Recent advances in central congenital hypothyroidism.

Authors:  Nadia Schoenmakers; Kyriaki S Alatzoglou; V Krishna Chatterjee; Mehul T Dattani
Journal:  J Endocrinol       Date:  2015-09-28       Impact factor: 4.286

10.  Screening for Mutations in Isolated Central Hypothyroidism Reveals a Novel Mutation in Insulin Receptor Substrate 4.

Authors:  Konrad Patyra; Kristiina Makkonen; Maria Haanpää; Sinikka Karppinen; Liisa Viikari; Jorma Toppari; Mary Pat Reeve; Jukka Kero
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-21       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.